References
- Wand O, Guber E, Guber A., et al. Inhaled tranexamic acid for hemoptysis treatment: a randomized controlled trial. Chest. 2018;154(6):1379–1384.
- Gopinath B, Mishra PR, Aggarwal P, et al. Nebulized vs IV Tranexamic Acid for Hemoptysis: A Pilot Randomized Controlled Trial. Chest. 2023;163(5):1176–1184.
- Solomonov A, Fruchter O, Zuckerman T, et al. Pulmonary hemorrhage: A novel mode of therapy. Respir Med. 2009;103(8):1196–200.
- Alabdrabalnabi F, Alshahrani M, Ismail N. Nebulized tranexamic acid for recurring hemoptysis in critically ill patients: case series. J Emerg Med. 2020;13:1–4.
- Chen LF, Wang TC, Lin TY, et al. Does tranexamic acid reduce risk of mortality on patients with hemoptysis? A protocol for systematic review and meta-analysis. Med. 2021;100(20):e25898.
- Myles PS, Smith JA, Forbes A, et al. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl Journal of Med. 2017;367(2);136–148.
- Hardin J, Seltzer J, Moriguchi R, et al. Tranexamic Acid Neurotoxicity After Nebulization and BAL. Chest. 2024;166(4):e101–e103.
- Sperzel M, Huetter J. Evaluation of aprotinin and tranexamic acid in different in vitro and in vivo models of fibrinolysis, coagulation and thrombus formation. J Thromb Haemost. 2007;5(10):2113–2118.